Polynucleotides encoding truncated glial cell line-derived neurotrophic factor
US7611865B2 · kind B2 · utility
5Cited by
13References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 26, 2004 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Jun 23, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel proteins, referred to as truncated glial cell line-derived neurotrophic factor (truncated GDNF) proteins, that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells. Also disclosed are processes for obtaining the truncated GDNF proteins by recombinant genetic engineering techniques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.